Ignacio Comer

Former Director of Quality at Horizon Pharma, Inc.

Ignacio Comer

Ignacio Comer

Former Director of Quality at Horizon Pharma, Inc.

Overview
RelSci Relationships

65

Contact Data
Trying to get in touch with Ignacio Comer? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Ignacio Comer likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chairman, President & Chief Executive Officer at Horizon Pharma PLC

Relationship likelihood: Weak

Vice President-Information Technology at Lundbeck, Inc.

Relationship likelihood: Weak

President, Chief Executive Officer & Secretary at La Jolla Pharmaceutical Co.

Relationship likelihood: Weak

Chief Financial Officer & Director at VisioMedtrics, Inc.

Relationship likelihood: Weak

Senior Vice President, Sales & Managed Care at Horizon Pharma USA, Inc.

Relationship likelihood: Weak

Former Chief Executive Officer & Executive Director at AGI Therapeutics Plc

Relationship likelihood: Weak

Former Chief of Staff at Horizon Pharma, Inc.

Relationship likelihood: Weak

Former Senior Director at Horizon Pharma, Inc.

Relationship likelihood: Weak

Former Senior Director at Horizon Pharma, Inc.

Relationship likelihood: Weak

Former Senior Director at Horizon Pharma, Inc.

Relationship likelihood: Weak

Paths to Ignacio Comer
Potential Connections via
Relationship Science
You
Ignacio Comer
Former Director of Quality at Horizon Pharma, Inc.
Career History
Director of Quality
Prior

Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.

Other Affiliations

Ignacio Comer is affiliated with Horizon Pharma, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ignacio Comer. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ignacio Comer's profile does not indicate a business or promotional relationship of any kind between RelSci and Ignacio Comer.